Intertek acquires BioClin Research Laboratories in Ireland

Published: 14-Feb-2008
Media Research & Development


UK-based Intertek Group, an international provider of quality and safety services to a wide range of industries, has acquired BioClin Research Laboratories Ltd, one of Ireland's leading suppliers of contract bioanalysis and analytical research and development.

Located in Athlone and with 20 staff, Bioclin offers advanced analytical services including liquid chromatography-tandem mass spectrometry (LC/MS/MS). The laboratory is GLP certified and is a cGMP facility that has been inspected by the Irish Medicines Board (IMB).

The acquisition advances Intertek's strategic growth in expert support services to the global pharmaceutical, medical device and drug delivery industry. Bioclin will operate in Intertek's pharmaceutical services group within its analytical services division.

"Bioclin further extends our offering in Europe as well as our global platform supporting pharmaceutical r&d and manufacturing in key locations," said Dr John Conti-Ramsden, global director of Intertek's Pharmaceutical Services. "Intertek already provides a wide range of testing services to pharmaceutical clients from its laboratories in the UK, US, India and Australia."

  • Companies:
  • Intertek
See more

You may also like

Research & Development

Intertek researches formulation strategies to repurpose biologic drugs

Read more
Achieving improvements in safety, efficacy and convenience for patients by using inhalation as an administration route

Trending Articles

  1. How flow chemistry is transforming drug discovery New Syrris eBook explores techniques driving efficiency and innovation
  2. Transmission Raman Spectroscopy - access the webinar series today Offering significant advantages for bulk, quantitative and non-destructive analysis, Transmission Raman Spectroscopy is a preferred choice for applications where surface analysis is insufficient or prone to errors. Speakers from Agilent, Novartis Pharma, AstraZeneca, Bristol-Myers Squibb and AbbVie go deeper in this FREE webinar series
  3. You need to be a subscriber to read this article.
    Click here to find out more.
    Parenteral preparations: formulation challenges Parenteral preparations are defined as solutions, suspensions, emulsions for injection or infusion, powders for injection or infusion, gels for injection and implants. They are sterile preparations that are administrated directly into the systemic circulation of humans or animals
  4. Peak identification by LC/MS: Automation versus analyst High pressure liquid chromatography/mass spectrometry (LC/MS) is an important technique that facilitates the correct and accurate identification of impurities in pharmaceutical products and intermediates
  5. Syncona launches early-stage drug development company, Slingshot Therapeutics The novel early-stage pharmaceutical company aims to collaborate with academic institutions to bring their findings to the clinic, with their first programme centring around inflammatory disease

Upcoming event

CPhI India

26–28 November 2024 | Online Conference & Networking | Delhi, India See all

You may also like

Research & Development

Intertek researches formulation strategies to repurpose biologic drugs

Achieving improvements in safety, efficacy and convenience for patients by using inhalation as an administration route
Regulatory

Intertek expands bioanalytical services in San Diego

Extra capacity and technologies will expedite bioanalytical studies for clients
Regulatory

Intertek expands lab operations in Manchester, UK

Opens new biologic medicine contract services laboratory to be used for the development of medicines such as monoclonal antibodies
Drug Delivery

Intertek launches comprehensive inhalation product development services

Aimed at both biologics and small molecules
Research & Development

Intertek acquires Melbourn Scientific

Combines advanced capabilities for measuring device/drug interaction with OINDP drug characterisation expertise
Research & Development

Intertek expert to present on advanced approaches to immunogenicity assessment

Dr Nancy Emtage will describe advanced approaches to assess the level of neutralisation antibodies in serum
Regulatory

Intertek acquires US-based QTI

<p>UK's Intertek Group, a scientific services company, has acquired Quantitative Technologies Inc (QTI). QTI will operate in the Intertek pharmaceutical services group.</p>
Subscribe now